OOIR: Observatory of International Research

Papers

(The TQCC of Beneficial Microbes is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Soymilk-fermented with Lactobacillus delbrueckii subsp. delbrueckii TUA4408L improves immune-health in pigs	57
Synergistic effects of Lacticaseibacillus rhamnosus GG, glutamine, and curcumin on chronic unpredictable mild stress-induced depression in a mouse model	55
Impact of Lactiplantibacillus plantarum Inducia on metabolic and antioxidative response in cholesterol and BMI variable indices: randomised, double-blind, placebo-controlled trials	37
Supplementation of honey bee production colonies with a native beneficial microbe mixture	32
The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes?	31
A critical evaluation of the factors affecting the survival and persistence of beneficial bacteria in healthy adults	29
Post-immunobiotics increase resistance to primary respiratory syncytial virus infection and secondary pneumococcal pneumonia	22
Evaluation of the effectiveness of personalised therapy for the patients with irritable bowel syndrome	19
Narrowing down the number of potential plant-based probiotic candidates by successive in vitro, technological and in vivo assays	17
Fermented rape pollen powder can alleviate benign prostatic hyperplasia in rats by reducing hormone content and changing gut microbiota	17
Safety assessment of Rhodobacter azotoformans SY5 for potential application in Chinese mitten crab Eriocheir sinensis	15
Lean and obese microbiota: differences in in vitro fermentation of food-by-products	15
Symptomatic relief from at-home use of activated Bifidobacterium infantis EVC001 probiotic in infants: results from a consumer survey on the effects on diaper rash, colic symptoms, and sleep	15
Are fructophilic lactic acid bacteria (FLAB) beneficial to humans?	15
Combination of Limosilactobacillus fermentum MG4231 and MG4244 attenuates lipid accumulation in high-fat diet-fed obese mice	15
Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial	14
Inadequate safety reporting in the publications of randomised clinical trials in irritable bowel syndrome: drug versus probiotic interventions	14
Effects of food matrix on the prebiotic efficacy of inulin-type fructans: a randomised trial	14
Inulin has a beneficial effect by modulating the intestinal microbiome in a BALB/c mouse model	14
Impact of oral galenic formulations of Lactobacillus salivarius on probiotic survival and interactions with microbiota in human in vitro gut models	14
Role of gastrointestinal microbial populations, a terra incognita of the human body in the management of intestinal bowel disease and metabolic disorders	13
Safety and tolerance of Lacticaseibacillus paracasei N1115 in caesarean-born young children: a randomised, placebo-controlled trial	13
Development of an ophthalmic formulation with a postbiotic of Lactiplantibacillus plantarum CRL 759	12
Long-term use of Lacticaseibacillus paracasei N1115 from early life alleviates high-fat-diet-induced obesity and dysmetabolism in mice	12
Probiotic Escherichia coli Nissle inhibits IL-6 and MAPK-mediated cardiac hypertrophy during STZ-induced diabetes in rats	11

Limosilactobacillus reuteri ATCC 6475 metabolites upregulate the serotonin transporter in the intestinal epithelium	11
Innovations for microbiome targeting interventions – a patent landscape analysis indicating overall patenting activity decline and promising target disease areas	10
Supplementation with heat-inactivated Lacticaseibacillus paracasei K47 ameliorates allergic asthma in mice by regulating the Th1/Th2 balance	10
Genomic, metabolomic, and functional characterisation of beneficial properties of Pediococcus pentosaceus ST58, isolated from human oral cavity	9
A blend of 3 mushrooms dose-dependently increases butyrate production by the gut microbiota	9
Lacticaseibacillus rhamnosus and breastmilk are associated with a decreased risk of atopic dermatitis in very low birth weight premature infants	9
Ageing and the gut-brain axis: lessons from the Drosophila model	9
Enterococcus faecium supplementation prevents enteritis caused by Escherichia coli in goats	9